KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 133 filers reported holding KARUNA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $26,641,989 | -14.7% | 157,561 | +9.4% | 0.01% | -16.7% |
Q2 2023 | $31,225,315 | -41.1% | 143,995 | -50.7% | 0.01% | -45.5% |
Q1 2023 | $53,022,169 | +0.2% | 291,908 | +8.4% | 0.01% | 0.0% |
Q4 2022 | $52,907,430 | -10.6% | 269,249 | +2.3% | 0.01% | -21.4% |
Q3 2022 | $59,192,000 | +101.8% | 263,155 | +13.5% | 0.01% | +133.3% |
Q2 2022 | $29,335,000 | +12.0% | 231,880 | +12.3% | 0.01% | +20.0% |
Q1 2022 | $26,190,000 | -7.3% | 206,561 | -4.2% | 0.01% | 0.0% |
Q4 2021 | $28,240,000 | +5.5% | 215,574 | -1.5% | 0.01% | 0.0% |
Q3 2021 | $26,765,000 | +3.8% | 218,791 | -3.2% | 0.01% | 0.0% |
Q2 2021 | $25,776,000 | +19.5% | 226,123 | +26.1% | 0.01% | +25.0% |
Q1 2021 | $21,567,000 | +16.5% | 179,382 | -1.6% | 0.00% | 0.0% |
Q4 2020 | $18,512,000 | +28.9% | 182,220 | -1.9% | 0.00% | +33.3% |
Q3 2020 | $14,365,000 | +5.1% | 185,777 | +51.5% | 0.00% | 0.0% |
Q2 2020 | $13,667,000 | +49.5% | 122,624 | -3.4% | 0.00% | 0.0% |
Q1 2020 | $9,140,000 | +75.3% | 126,946 | +83.4% | 0.00% | +200.0% |
Q4 2019 | $5,215,000 | +380.6% | 69,214 | +4.1% | 0.00% | – |
Q3 2019 | $1,085,000 | – | 66,485 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |